For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

Newcastle University

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors

Type
D - Journal article
Title of journal
Journal of Clinical Oncology
Article number
-
Volume number
28
Issue number
25
First page of article
3965
ISSN of journal
1527-7755
Year of publication
2010
Number of additional authors
15
Additional information

The author made a substantial contribution to carrying out the study (including acquisition of study data), to analysis and interpretation of study data, AND the author helped draft the output and critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
B - Cancer
Citation count
98
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-